AAVATAR Therapeutics

AAVATAR Therapeutics contributes to a sustainable future through gene therapy innovation.
We uphold environmental stewardship, social responsibility, and transparent corporate governance as core values.

From R&D to manufacturing, we ensure sustainability in every process,

adopting eco‑friendly practices and resource efficiency.

We are committed to developing treatments for underrepresented patients,

forging equitable partnerships, and maintaining transparent operations to actively realize ESG management.

April 7, 2025
Seunghee Cho, CEO, AAVATAR Therapeutics

AAVATAR Therapeutics is committed to responding swiftly and fairly to reports concerning bribery, misconduct, ethical violations, and unfair practices by employees or associated parties.

* Reports will be handled confidentially and anonymously, and the identity of the whistleblower will be strictly protected.

▪ Confidentiality Assurance

Disclosure or suggestion of the whistleblower’s identity without their explicit consent is strictly prohibited.

▪ Protection of Identity

Whistleblowers shall be protected from any disadvantage or discrimination—

such as disciplinary action or unfair treatment by their department or business partners—arising from reporting, testimony, or submission of materials.